5-(2,6-dimethylimidazo[1,2-a]pyridine-3-carbonyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carbonitrile
C17H16N6O — CID 50961108
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(2,6-dimethylimidazo[1,2-a]pyridine-3-carbonyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carbonitrile
5-(2,6-dimethylimidazo[1,2-a]pyridine-3-carbonyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carbonitrile (PubChem CID 50961108) has the molecular formula C17H16N6O and a molecular weight of 320.36 g/mol. Its IUPAC name is 5-(2,6-dimethylimidazo[1,2-a]pyridine-3-carbonyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carbonitrile.
Molecular Properties
| Compound Name | 5-(2,6-dimethylimidazo[1,2-a]pyridine-3-carbonyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carbonitrile |
|---|---|
| PubChem CID | 50961108 |
| Molecular Formula | C17H16N6O |
| Molecular Weight | 320.36 g/mol |
| Exact Mass | 320.14 |
| IUPAC Name | 5-(2,6-dimethylimidazo[1,2-a]pyridine-3-carbonyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carbonitrile |
| SMILES | Cc1ccc2nc(C)c(C(=O)N3CCn4nc(C#N)cc4C3)n2c1 |
| InChI | InChI=1S/C17H16N6O/c1-11-3-4-15-19-12(2)16(22(15)9-11)17(24)21-5-6-23-14(10-21)7-13(8-18)20-23/h3-4,7,9H,5-6,10H2,1-2H3 |
| InChIKey | PPVUAEOUKWOGOZ-UHFFFAOYSA-N |
| XLogP | 1.68 |
| TPSA | 79.22 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 320.36 |
| LogP ≤ 5 | 1.68 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 50961108 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.